Can-Fite BioPharma
Can-Fite BioPharma Ltd. is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for cancer and inflammatory diseases. The company is primarily engaged in the research and development of a unique platform of small molecules, including its lead product candidates, which target the A3 adenosine receptor for the treatment of various conditions, such as psoriasis, rheumatoid arthritis, and cancer. Can-Fite operates within the biotechnology sector, leveraging its proprietary drug development capabilities to advance its pipeline and bring novel treatments to market.